Search

Your search keyword '"Bellissant E"' showing total 297 results

Search Constraints

Start Over You searched for: Author "Bellissant E" Remove constraint Author: "Bellissant E" Language english Remove constraint Language: english
297 results on '"Bellissant E"'

Search Results

1. Multicentre, prospective, double-blind, randomised controlled clinical trial comparing different non-opioid analgesic combinations with morphine for postoperative analgesia: the OCTOPUS study

4. Efficacy, safety and patient‐reported outcomes of ledipasvir/sofosbuvir in NS3/4A protease inhibitor‐experienced individuals with hepatitis C virus genotype 1 and HIV coinfection with and without cirrhosis (ANRS HC31 SOFTRIH study)

5. Overview of literature monitoring practices of clinical trials vigilance units in French institutional sponsors-A study from the REVISE working group

6. Switch from intravenous to subcutaneous infliximab in inflammatory bowel disease: Which consequences from a pharmacokinetic perspective?

7. Simultaneous quantification of infliximab and adalimumab in human plasma by liquid chromatography-tandem mass spectrometry using ready-to-use kit and comparison with two ELISA methods

8. Therapeutic drug monitoring of ruxolitinib in graft versus host disease in pediatric allogenic hematopoietic stem cell transplant recipients: A multicenter retrospective study

9. An easy, fast and inexpensive multiplex pharmacogenetics assay to simultaneously analyze 17 clinically relevant genetic polymorphisms in CYP3A4, CYP3A5, CYP1A2, CYP2C9, CYP2C19, CYP2D6, ABCB1 and VKORC1 genes

10. Contribution of voriconazole phenotyping to patient management

14. Vigilance of clinical trials: Retrospective analysis of working time and associated costs for a completed study

15. Deciphering pharmacogenetic-whole blood/intracellular pharmacokinetic-pharmacodynamic (PG-PK2-PD) relationship of tacrolimus in liver transplant recipients

16. Redefining therapeutic drug monitoring of tacrolimus in liver transplantation: can we target trough concentrations below 7 ng/ml during the first month?

17. Pharmacokinetic-pharmacodynamic profile in patients treated with ceftaroline: A retrospective study

18. A case report of a therapeutic drug monitoring-guided sofosbuvir-velpatasvir crushed treatment

19. Clinical trials vigilance: Comparison of sponsor and investigator's imputabilities of serious adverse events in a randomized, double-blinded study

20. Results of one year reconciliation activity in Rennes clinical trials vigilance unit

21. Validation of a high-performance liquid chromatography-tandem mass spectrometry method for the quanYtification of beta-lactams in cardiac valves

26. Assessment of time spent for Clinical trial vigilance activities in an academic Trials Vigilance Unit

27. Pharmacokinetic and pharmacodynamic profile of beta-lactam antibiotics in patients treated for infective endocarditis a five-year retrospective study

28. Beta-lactams and Proton Pump Inhibitors a new example of renal transporters mediated drug-drug interaction

39. Safety study and therapeutic drug monitoring of the oral tablet formulation of posaconazole in patients with haematological malignancies

40. Cost-effectiveness of full versus targeted monitoring of randomized controlled trials

47. High intrapatient variability of tacrolimus exposure is associated with poorer outcomes after liver transplantation

48. Retreatment with sofosbuvir plus grazoprevir plus elbasvir plus ribavirin of patients with Hepatitis C virus Genotype 1 or 4 with RASs at failure of a sofosbuvir plus ledipasvir or plus daclatasvir or plus simeprevir regimen (ANRS HC34 REVENGE study)

49. Population kinetics of factor VIII in mild hemophilia A patients following desmopressin intravenous administration

Catalog

Books, media, physical & digital resources